{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:13:16Z","timestamp":1724717596249},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,25]]},"DOI":"10.7759\/cureus.67760","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T03:17:31Z","timestamp":1724642251000},"source":"Crossref","is-referenced-by-count":0,"title":["Cochlear Implantation for Isoleucyl-tRNA Synthetase Mutation-Associated Mitochondrial Disease: A Case Report"],"prefix":"10.7759","author":[{"given":"Masaomi","family":"Motegi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuika","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Mio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toya","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.1.82","article-title":"The spectrum of hearing loss due to mitochondrial DNA defects","volume":"123","author":"Chinnery PF","year":"2000","unstructured":"Chinnery PF, Elliott C, Green GR, Rees A, Coulthard A, Turnbull DM, Griffiths TD. The spectrum of hearing loss due to mitochondrial DNA defects. Brain. 2000, 123:82-92. 10.1093\/brain\/123.1.82","journal-title":"Brain"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1086\/301676","article-title":"Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides","volume":"62","author":"Estivill X","year":"1998","unstructured":"Estivill X, Govea N, Barcel\u00f3 E, et al.. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides. Am J Hum Genet. 1998, 62:27-35. 10.1086\/301676","journal-title":"Am J Hum Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.32.4.257","article-title":"A new X linked recessive deafness syndrome with blindness, dystonia, fractures, and mental deficiency is linked to Xq22","volume":"32","author":"Tranebjaerg L","year":"1995","unstructured":"Tranebjaerg L, Schwartz C, Eriksen H, et al.. A new X linked recessive deafness syndrome with blindness, dystonia, fractures, and mental deficiency is linked to Xq22. J Med Genet. 1995, 32:257-63. 10.1136\/jmg.32.4.257","journal-title":"J Med Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2016.05.027","article-title":"Biallelic IARS mutations cause growth retardation with prenatal onset, intellectual disability, muscular hypotonia, and infantile hepatopathy","volume":"99","author":"Kopajtich R","year":"2016","unstructured":"Kopajtich R, Murayama K, Janecke AR, et al.. Biallelic IARS mutations cause growth retardation with prenatal onset, intellectual disability, muscular hypotonia, and infantile hepatopathy. Am J Hum Genet. 2016, 99:414-22. 10.1016\/j.ajhg.2016.05.027","journal-title":"Am J Hum Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200305000-00012","article-title":"A review of cochlear implantation in mitochondrial sensorineural hearing loss","volume":"24","author":"Sinnathuray AR","year":"2003","unstructured":"Sinnathuray AR, Raut V, Awa A, Magee A, Toner JG. A review of cochlear implantation in mitochondrial sensorineural hearing loss. Otol Neurotol. 2003, 24:418-26. 10.1097\/00129492-200305000-00012","journal-title":"Otol Neurotol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/287432","article-title":"Mitochondrial sensorineural hearing loss: a retrospective study and a description of cochlear implantation in a MELAS patient","volume":"2012","author":"Scarpelli M","year":"2012","unstructured":"Scarpelli M, Zappini F, Filosto M, Russignan A, Tonin P, Tomelleri G. Mitochondrial sensorineural hearing loss: a retrospective study and a description of cochlear implantation in a MELAS patient. Genet Res Int. 2012, 2012:287432. 10.1155\/2012\/287432","journal-title":"Genet Res Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1126\/science.7701325","article-title":"High-frequency motility of outer hair cells and the cochlear amplifier","volume":"267","author":"Dallos P","year":"1995","unstructured":"Dallos P, Evans BN. High-frequency motility of outer hair cells and the cochlear amplifier. Science. 1995, 267:2006-9. 10.1126\/science.7701325","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1126\/science.283.5407.1482","article-title":"Mitochondrial diseases in man and mouse","volume":"283","author":"Wallace DC","year":"1999","unstructured":"Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999, 283:1482-8. 10.1126\/science.283.5407.1482","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430313","article-title":"Cochlear origin of hearing loss in MELAS syndrome","volume":"43","author":"Sue CM","year":"1998","unstructured":"Sue CM, Lipsett LJ, Crimmins DS, et al.. Cochlear origin of hearing loss in MELAS syndrome. Ann Neurol. 1998, 43:350-9. 10.1002\/ana.410430313","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199601000-00010","article-title":"Auditory findings in patients with maternally inherited diabetes and deafness harboring a point mutation in the mitochondrial transfer RNA(Leu) (UUR) gene","volume":"106","author":"Yamasoba T","year":"1996","unstructured":"Yamasoba T, Oka Y, Tsukuda K, Nakamura M, Kaga K. Auditory findings in patients with maternally inherited diabetes and deafness harboring a point mutation in the mitochondrial transfer RNA(Leu) (UUR) gene. Laryngoscope. 1996, 106:49-53. 10.1097\/00005537-199601000-00010","journal-title":"Laryngoscope"},{"key":"ref11","article-title":"Successful cochlear implantation in a patient with MELAS syndrome","volume":"20","author":"Rosenthal EL","year":"1999","unstructured":"Rosenthal EL, Kileny PR, Boerst A, Telian SA. Successful cochlear implantation in a patient with MELAS syndrome. Am J Otol. 1999, 20:187-90; discussion 190-1.","journal-title":"Am J Otol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0000000000000817","article-title":"The outcome of cochlear implantation for mitochondrial disease patients with syndromic hearing loss","volume":"36","author":"Yamamoto N","year":"2015","unstructured":"Yamamoto N, Okuyama H, Hiraumi H, Sakamoto T, Matsuura H, Ito J. The outcome of cochlear implantation for mitochondrial disease patients with syndromic hearing loss. Otol Neurotol. 2015, 36:e129-33. 10.1097\/MAO.0000000000000817","journal-title":"Otol Neurotol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199304000-00035","article-title":"Anesthetic considerations in patients with mitochondrial dysfunction","volume":"76","author":"Maslow A","year":"1993","unstructured":"Maslow A, Lisbon A. Anesthetic considerations in patients with mitochondrial dysfunction. Anesth Analg. 1993, 76:884-6. 10.1213\/00000539-199304000-00035","journal-title":"Anesth Analg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2002.025015","article-title":"Halothane, isoflurane and sevoflurane inhibit NADH: ubiquinone oxidoreductase (complex I) of cardiac mitochondria","volume":"544","author":"Hanley PJ","year":"2002","unstructured":"Hanley PJ, Ray J, Brandt U, Daut J. Halothane, isoflurane and sevoflurane inhibit NADH: ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol. 2002, 544:687-93. 10.1113\/jphysiol.2002.025015","journal-title":"J Physiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2006.11.004","article-title":"The peripheral-type benzodiazepine receptor is involved in control of Ca2+-induced permeability transition pore opening in rat brain mitochondria","volume":"42","author":"Azarashvili T","year":"2007","unstructured":"Azarashvili T, Grachev D, Krestinina O, Evtodienko Y, Yurkov I, Papadopoulos V, Reiser G. The peripheral-type benzodiazepine receptor is involved in control of Ca2+-induced permeability transition pore opening in rat brain mitochondria. Cell Calcium. 2007, 42:27-39. 10.1016\/j.ceca.2006.11.004","journal-title":"Cell Calcium"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2015.11.004","article-title":"Perioperative considerations in adult mitochondrial disease: a case series and a review of 111 cases","volume":"26","author":"Miyamoto Y","year":"2016","unstructured":"Miyamoto Y, Miyashita T, Takaki S, Goto T. Perioperative considerations in adult mitochondrial disease: a case series and a review of 111 cases. Mitochondrion. 2016, 26:26-32. 10.1016\/j.mito.2015.11.004","journal-title":"Mitochondrion"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9592.2006.02043.x","article-title":"Anesthesia-related morbidity and mortality after surgery for muscle biopsy in children with mitochondrial defects","volume":"17","author":"Driessen J","year":"2007","unstructured":"Driessen J, Willems S, Dercksen S, Giele J, van der Staak F, Smeitink J. Anesthesia-related morbidity and mortality after surgery for muscle biopsy in children with mitochondrial defects. Paediatr Anaesth. 2007, 17:16-21. 10.1111\/j.1460-9592.2006.02043.x","journal-title":"Paediatr Anaesth"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aen014","article-title":"Mitochondrial disorders and general anaesthesia: a case series and review","volume":"100","author":"Footitt EJ","year":"2008","unstructured":"Footitt EJ, Sinha MD, Raiman JA, Dhawan A, Moganasundram S, Champion MP. Mitochondrial disorders and general anaesthesia: a case series and review. Br J Anaesth. 2008, 100:436-41. 10.1093\/bja\/aen014","journal-title":"Br J Anaesth"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2004.07.012","article-title":"Surgical and anesthetic management of patients with mitochondrial dysfunction","volume":"4","author":"Edmonds JL Jr","year":"2004","unstructured":"Edmonds JL Jr. Surgical and anesthetic management of patients with mitochondrial dysfunction. Mitochondrion. 2004, 4:543-8. 10.1016\/j.mito.2004.07.012","journal-title":"Mitochondrion"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.02.010","article-title":"Permeabilised skeletal muscle reveals mitochondrial deficiency in malignant hyperthermia-susceptible individuals","volume":"122","author":"Chang L","year":"2019","unstructured":"Chang L, Daly C, Miller DM, Allen PD, Boyle JP, Hopkins PM, Shaw MA. Permeabilised skeletal muscle reveals mitochondrial deficiency in malignant hyperthermia-susceptible individuals. Br J Anaesth. 2019, 122:613-21. 10.1016\/j.bja.2019.02.010","journal-title":"Br J Anaesth"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/287888-cochlear-implantation-for-isoleucyl-trna-synthetase-mutation-associated-mitochondrial-disease-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T03:17:36Z","timestamp":1724642256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/287888-cochlear-implantation-for-isoleucyl-trna-synthetase-mutation-associated-mitochondrial-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,25]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.67760","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,25]]}}}